March 17, 2026

Good morning. A few things of note:

  • STAT's Breakthrough Summit in New York City is later this week. Register for online or in-person access here, and get the rundown of all our oncology-related events here.
  • For a limited time, you can get 50% off an annual STAT subscription. If you're interested in seizing the day — and supporting our science journalism for a deal — this is for you.
Andrew Harnik/Getty Images

STAT+ | White House digs in on ‘most-favored nation’ drug pricing despite Congress’ cool reception

White House turns up pressure on lawmakers on turning voluntary MFN deals into law. 'We’re gearing up for war,' White House official says.

By Daniel Payne


STAT+ | Grail CEO steps down after trial setback

Today's biotech news covers Grail CEO stepping down, Epstein's pal returning to biotech, and Prasad's FDA exit part deux

By STAT Staff and Meghana Keshavan


Major changes to cardiovascular guidelines suggest taking statins as young as 30 

Leading cardiology groups say adults should assess cholesterol risk at younger age and consider treatment to prevent heart attacks and strokes.

By Elizabeth Cooney



Camille MacMillin/STAT

STAT+ | New technologies promise to transform organ transplantation. But when?

Perfusion technology vastly improves organ quality in transplants, but high costs and coverage questions pose barriers in becoming the standard of care.

By Elizabeth Cooney


More around STAT

In case you missed it

  • Brain tumor survivors are forcing a rethink of cancer care, Bloomberg
  • Cancer haunts neighbors of Canada's oil sands wastelands, New York Times

Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Cancer Briefing? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.